- Home
- IMTX vs GUG Comparison
IMTX vs GUG Comparison
Compare IMTX & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- GUG
- Stock Information
- Founded
- IMTX N/A
- GUG 2021
- Country
- IMTX Germany
- GUG United States
- Employees
- IMTX N/A
- GUG N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- GUG Trusts Except Educational Religious and Charitable
- Sector
- IMTX Health Care
- GUG Finance
- Exchange
- IMTX Nasdaq
- GUG Nasdaq
- Market Cap
- IMTX 514.2M
- GUG 499.3M
- IPO Year
- IMTX N/A
- GUG N/A
- Fundamental
- Price
- IMTX $4.26
- GUG $14.37
- Analyst Decision
- IMTX Strong Buy
- GUG
- Analyst Count
- IMTX 4
- GUG 0
- Target Price
- IMTX $16.67
- GUG N/A
- AVG Volume (30 Days)
- IMTX 849.5K
- GUG 108.9K
- Earning Date
- IMTX 05-13-2025
- GUG 01-01-0001
- Dividend Yield
- IMTX N/A
- GUG 9.67%
- EPS Growth
- IMTX N/A
- GUG N/A
- EPS
- IMTX 0.14
- GUG N/A
- Revenue
- IMTX $161,336,577.00
- GUG N/A
- Revenue This Year
- IMTX N/A
- GUG N/A
- Revenue Next Year
- IMTX $18.80
- GUG N/A
- P/E Ratio
- IMTX $29.39
- GUG N/A
- Revenue Growth
- IMTX 188.60
- GUG N/A
- 52 Week Low
- IMTX $3.30
- GUG $12.71
- 52 Week High
- IMTX $13.77
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- IMTX 48.54
- GUG 40.51
- Support Level
- IMTX $4.03
- GUG $14.09
- Resistance Level
- IMTX $4.48
- GUG $14.68
- Average True Range (ATR)
- IMTX 0.39
- GUG 0.40
- MACD
- IMTX 0.05
- GUG -0.01
- Stochastic Oscillator
- IMTX 75.00
- GUG 32.19
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.